We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2008 by Johannes Gutenberg University Mainz.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT00792649
First Posted: November 18, 2008
Last Update Posted: November 18, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Johannes Gutenberg University Mainz
November 17, 2008
November 18, 2008
November 18, 2008
February 2008
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy
Not Provided
Colonoscopy is the accepted gold standard for screening of colorectal cancer. However, small and flat neoplastic lesions might be overlooked with standard video endoscopes. The new available EPKi system (Pentax, Japan) enables with HD+ imaging resolution above HDTV standard. Aim of the study was to test the efficacy of HD+ colonoscopy alone and in conjunction with I-Scan (newly developed post processing digital filter)in comparison to standard videoendoscopy
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Consecutive patients scheduled for screening colonoscopy were examined using HD+ colonosccopes and standardendoscopes.
  • Polyps
  • Neoplasia
Not Provided
  • 1
    screening colonoscopy with HD+ endoscopes
  • 2
    screening colonoscopy with standardvideoendoscopes
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
200
Not Provided
Not Provided

Inclusion Criteria:

  • Consecutive patients scheduled for screening colonoscopy

Exclusion Criteria:

  • Inflammatory bowel disease
  • Cancer
  • Pregnancy
  • Inability to obtain informed consent
  • Prothrombin time < 50% of control
  • Partial thromboplastin time > 50 seconds
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00792649
837.386.07
No
Not Provided
Not Provided
Hoffman Arthur
Johannes Gutenberg University Mainz
Not Provided
Not Provided
Johannes Gutenberg University Mainz
February 2008